AzTrials
AzTrials

ARDSNCT04067154

Gas Exchange and CT Effects of PEEP in ARDS

A study testing ALPE in people with ARDS, run by Policlinico Hospital at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to investigate the association between effects of PEEP on gas exchange model parameters and CT scan results Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
ARDS
What is being tested?
ALPE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
13 participants
Where
1 siteItaly
Study dates
1 Aug 2012to 1 Aug 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ARDS patients requiring mechanical ventilation

Who cannot join

  • <18 years old
  • Requirement of extracorporal life support
  • Hemodynamic instability
  • Barotrauma

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Milan, MI, 20122

Other trials in Italy

About this study

Official title: Does a Bedside Method for Describing Functional Gas Exchange Compare Well With Anatomical Description Via CT Scans, and Could it Predict the Effects of Recruitment and Ventilation/Perfusion Mismatch Improvement

The study aims to investigate the association between effects of PEEP on gas exchange model parameters and CT scan results

Read the detailed description

In ARDS patients on mechanical ventilation, we will compare model-based estimation of gas exchange parameters (shunt, ventilation/perfusion mismatch) with CT-based estimation of effects of low and high PEEP

Conditions
ARDS
Being tested
ALPE

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ALPEDiagnostic test

    Measurement of CT scan at PEEP of 5, 20 and 45 cm H2O Measurement of gas exchange by model-based method and FiO2 titration at PEEP of 5 and 20 cm H2O

Study groups in NCT04067154
Study groupRoleWhat they receive
ALPE-TACExperimentalARDS patients on mechanical ventilation. Measurement of CT scan at PEEP of 5, 20 and 45 cm H2O to evaluate potential for recruitment and measurement of gas exchange by model-based method and FiO2 titration at PEEP of 5 and 20 cm H2O
Receives: Diagnostic Test: ALPE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gas Exchange and lung recruitability at diferent PEEP levels

    Gas exchange (At PEEP 5 and 20 cm H2O), CT scan (At PEEP 5, 20 and 45 cm H2O)

    Measured: Approximately two hours

Secondary outcomes (2)
  1. Physiologic Parameter 1

    Hemodynamic assessment at different PEEP levels

    Measured: Approximately two hours

  2. Physiologic Parameter 2

    Respiratory mechanics at different PEEP levels

    Measured: Approximately two hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2019
  2. Study start1 Aug 2012
  3. Primary completion1 Aug 2014
  4. Study completion1 Aug 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
13 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04067154
Sponsor's protocol ID
2425
Status last verified
Aug 2019
First submitted
21 Aug 2019
Last updated
26 Aug 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Karbing DS, Panigada M, Bottino N, Spinelli E, Protti A, Rees SE, Gattinoni L. Changes in shunt, ventilation/perfusion mismatch, and lung aeration with PEEP in patients with ARDS: a prospective single-arm interventional study. Crit Care. 2020 Mar 23;24(1):111. doi: 10.1186/s13054-020-2834-6.

    PubMed 32293506

Questions about this trial

What is this clinical trial studying?

A study testing ALPE in people with ARDS, run by Policlinico Hospital at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gas Exchange and lung recruitability at diferent PEEP levels (time frame: Approximately two hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04067154, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in